PROGNOSTIC IMPORTANCE OF MYELOSUPPRESSION DURING MAINTENANCE TREATMENT OF LYMPHOBLASTIC-LEUKEMIA

被引:23
作者
DOLAN, G
LILLEYMAN, JS
RICHARDS, SM
机构
[1] CHILDRENS HOSP,DEPT HAEMATOL,SHEFFIELD S10 2TH,S YORKSHIRE,ENGLAND
[2] RADCLIFFE INFIRM,CLIN TRIAL SERV UNIT,OXFORD OX2 6HE,ENGLAND
关键词
D O I
10.1136/adc.64.9.1231
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:1231 / 1234
页数:4
相关论文
共 8 条
[1]  
PINKEL D, 1971, CANCER-AM CANCER SOC, V27, P247, DOI 10.1002/1097-0142(197102)27:2<247::AID-CNCR2820270202>3.0.CO
[2]  
2-C
[3]  
PINKEL D, 1987, LANCET, V2, P1267
[4]   WHITE CELL COUNT DURING MAINTENANCE CHEMOTHERAPY FOR STANDARD RISK CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - RELATION TO RELAPSE RATE [J].
SCHMIEGELOW, K ;
PULCZYNSKA, MK ;
SEIP, M .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1988, 5 (04) :259-267
[5]  
VANEYS J, 1981, P AM ASSOC CANC RES, V22, P478
[6]  
1971, BRIT MED J, V4, P189
[7]  
1986, LANCET, V1, P408
[8]  
1986, J CLIN ONCOL, V4, P1758